Eagle Bay Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-97
Closed -$1.27K 625
2024
Q4
$1.27K Buy
97
+78
+411% +$1.08K ﹤0.01% 930
2024
Q3
$220 Hold
19
﹤0.01% 1329
2024
Q2
$143 Sell
19
-212
-92% -$1.75K ﹤0.01% 974
2024
Q1
$2.32K Buy
231
+165
+250% +$1.53K ﹤0.01% 863
2023
Q4
$613 Sell
66
-2,032
-97% -$21K ﹤0.01% 797
2023
Q3
$26.7K Buy
2,098
+1,261
+151% +$17.3K 0.01% 496
2023
Q2
$11.9K Sell
837
-986
-54% -$13.8K 0.01% 585
2023
Q1
$27.2K Buy
1,823
+1,093
+150% +$16.6K 0.01% 499
2022
Q4
$10.8K Sell
730
-141
-16% -$2.3K 0.01% 598
2022
Q3
$14K Sell
871
-724
-45% -$14.6K 0.01% 554
2022
Q2
$33.5K Buy
1,595
+878
+122% +$17.9K 0.02% 454
2022
Q1
$17K Sell
717
-276
-28% -$6.76K 0.01% 237
2021
Q4
$27K Buy
993
+229
+30% +$6.13K 0.02% 509
2021
Q3
$21K Sell
764
-178
-19% -$5.42K 0.01% 605
2021
Q2
$30K Buy
+942
New +$27.8K 0.02% 459

Other funds holding MD

Eagle Bay Advisors's MD Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Pediatrix Medical (MD) in Q1 2025, closing a stake of 97 shares — an estimated $1.27K sold.

Eagle Bay Advisors first reported a position in MD in Q2 2021 and held it in 15 quarters. The position peaked at $33.5K in Q2 2022. 241 funds tracked by Wall St. Rank hold MD as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Pediatrix Medical position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 97 Pediatrix Medical shares in Q1 2025, an estimated $1.27K.
  • Eagle Bay Advisors first reported a position in Pediatrix Medical in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Pediatrix Medical position peaked at $33.5K in Q2 2022.
  • 241 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.